Chemotherapy Related Biomarker in Triple negative breast cancer
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: null- Tissue blocks from women with non-metastatic, TNBC breast cancer, who are eligible for neoadjuvant chemotherapy and have received NACT under the ongoing randomized trial at TMC
- Registration Number
- CTRI/2018/05/014158
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Tissue blocks from women with non-metastatic, triple negative breast cancer, who are eligible for neoadjuvant chemotherapy and have received NACT under the ongoing randomized trial at TMC (CTRI/2012/07/002802), will be included in the study.
TNBC with available paired paraffin samples (pre-NACT and post-surgery) will be included.
Exclusion Criteria
Metastatic Breast Cancer patient
Non TNBC
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method